Skip to main content
Pharmaceuticals logoLink to Pharmaceuticals
. 2024 Mar 25;17(4):411. doi: 10.3390/ph17040411

Correction: Palmeira et al. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals 2020, 13, 132

Andreia Palmeira 1,2, Emília Sousa 1,2, Aylin Köseler 3,*, Ramazan Sabirli 4, Tarık Gören 5, İbrahim Türkçüer 5, Özgür Kurt 6, Madalena M Pinto 1,2, M Helena Vasconcelos 7,8,9,*
PMCID: PMC11054617  PMID: 38675502

Text Correction

There was an error in the original publication. In the introduction of the paper [1], GRP78 was incorrectly also named as Byun1.

A correction has been made to Introduction, third paragraph:

Glucose Regulated Protein 78 (GRP78), also known as Binding immunoglobulin protein (BiP) or heat shock 70 kDa protein 5 (HSPA5), is a HSP70 molecular chaperone encoded by the HSPA5 gene.

The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Reference

  • 1.Palmeira A., Sousa E., Köseler A., Sabirli R., Gören T., Türkçüer İ., Kurt Ö., Pinto M.M., Vasconcelos M.H. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals. 2020;13:132. doi: 10.3390/ph13060132. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Pharmaceuticals are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES